Neuropsychobiology

Biological PsychiatryMain Editor: J. Mendlewicz (Brussels)Original Paper

Gender-Related Seasonality of Human Platelet Phenolsulfotransferase Activity

Marazziti D. · Palego L. · Rossi A. · Cassano G.B.

Author affiliations

Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, Università di Pisa, Italia

Related Articles for ""

Neuropsychobiology 1998;38:1–5

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Biological PsychiatryMain Editor: J. Mendlewicz (Brussels)Original Paper

Published online: August 14, 1998
Issue release date: August 1998

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

This study focused on the investigation of the possible effect of gender and season on the activity of the thermolabile and thermostable forms of platelet phenolsulfotransferase (PST) in a group of 23 healthy, drug-free volunteers of both sexes. The results showed a different seasonal profile of PST activity in men and women: in men, PST seasonal rhythms revealed a shallow profile with higher values in both the spring and summer than in the autumn. Conversely, in women, the PST seasonality showed a profile consisting overall of a main peak in the summer. Also, significant gender-dependent correlations were found between the photoperiod length and PST values. Our findings should stimulate further investigation into gender-dependent molecular mechanisms underlying the regulation of the metabolism of endogenous and xenobiotic agents, such as monoamines and phenols, which are the substrates of PST.




Related Articles:


References

  1. Roy AB: Sulfotransferases; in Mulder GJ (ed): Sulfation of drugs and related compounds. Boca Raton, CRC Press, 1981, pp 83–103.
  2. Rein G, Grainer V, Sandler M: Multiple forms of phenolsulphotransferase in human tissues: Selective inhibition by dichloronitrophenol. Biochem Pharmacol 1982;31:1893–1897.
  3. Reiter C, Weinshilboum RM: Acetaminophen and phenol: Substrates for both a thermostable and a thermolabile form of human platelet phenol sulphotransferase. J Pharmacol Exp Ther 1982;221:43–51.
  4. Bonham-Carter SM, Rein G, Glover V, Sandler M, Caldwell J: Human platelet phenolsulfotransferase M and P: Substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. Br J Clin Pharmacol 1983;15:323–329.
    External Resources
  5. Whittemore RM, Pearce LB, Roth JA: Purification and kinetic characterization of phenol sulfotransferase from human brain, Biochemistry 1985;24:2477–2482.
  6. Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z, Siciliano MJ: Genomic organization of human phenolsulfotransferase gene. Genomics 1993;18:440–443.
  7. Dooley TP, Huang Z: Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16. Biochem Biophys Res Commun 1996;228:134–140.
  8. Campbell NRC, Van Loon JA, Weinshilboum RM: Characterization of phenol sulfotransferase in human tissues. Biochem Pharmacol 1987;36:1435–1446.
  9. Rensker KJ, Feor KD, Roth JA: Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. J Neurochem 1980;34:1362–1368.
    External Resources
  10. Karoum F, Moyer-Schwing J, Potkin SG, Wyatt R: Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res 1977;125:333–339.
  11. Rivett AJ, Eddy BJ, Roth JA: Contribution of sulfate conjugation, deamination and O-methylation to metabolism of dopamine and norepinephrine in human brain. J Neurochem 1984;39:1009–1016.
  12. Wong KP, Khoo BY, Tan TMC, Sit KH: Phenolsulfotransferase (PST) and PAPS in catecholamine metabolism in human tissues: an overview. J Neural Transm Suppl 1990;29:163–171.
  13. Butler PR, Anderson RJ, Venton DL: Human platelet phenol sulfotransferase: Partial purification and detection of two forms of the enzyme. J Neurochem 1983;41:630–639.
  14. Van Loon JA, Weinshilboum RM: Human platelet phenol sulfotransferase: Familial variation in thermal stability of the TS form. Biochem Genet 1984;22:997–1014.
    External Resources
  15. Young WF Jr, Laws ER Jr, Sharbrough FW, Weinshilboum RM: Human phenol sulfotransferase: Correlation of brain and platelet activities. J Neurochem 1985;44:1131–1137.
    External Resources
  16. Akiyoshi J, Kuranaga H, Tsuchiyama K, Nagayama H: Circadian rhythms of serotonin receptor in rat brain. Pharmacol Biochem Behav 1986;32:491–493.
  17. Kafka MK, Benedito MA, Blendy JA, Tokola NS: Circadians rhythms in catecholamine metabolites and cyclic nucleotide production. Chronobiol Int 1986;3:101–106.
  18. Marazziti D, Palego L, Mazzanti C, Silvestri S, Cassano GB: Human platelet sulfotransferase shows seasonal rhythms. Chronobiol Int 1995;2:100–105.
  19. Marazziti D, Rossi A, Palego L, Barsanti A, Carrai M, Giannaccini G, Serra P, Lucacchini A, Cassano GB: Effects of aging and sex on the 3H-paroxetine binding to human platelets. J Affect Disord, in press.
  20. Palego L, Marazziti D, Rossi A, Giannaccini G, Naccarato AG, Lucacchini A, Cassano GB: Apparent absence of gender and aging effects on serotonin 1A receptors in human neocortex and hippocampus. Brain Res 1997;758:26–32.
    External Resources
  21. Cassano GB, Musetti L, Perugi G: A proposed new approach to the clinical subclassification of depressive illness. Pharmacopsychiatry 1988;21:19–23.
    External Resources
  22. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1980;23:189–192.
  23. Cassano GB, Castrogiovanni P: SAD, Scala di Autovalutazione della depressione. International Committee for Prevention and Treatment of Depression; in Cassano GB (ed): La condizione depressiva. Milan, Masson, 1982, pp 483–486.
  24. Folks DG: MAO: Reappraisal of dietary considerations. J Clin Psychopharmacol 1983;3:249–254.
    External Resources
  25. Foldes A, Meek JL: Rat brain phenolsulphotransferase. Partial purification and some properties. Biochem Biophys Acta 1973;327:365–374.
  26. Anderson RJ, Weinshilboum RM: Phenolsulfotransferase in human tissues: Radiochemical enzymatic assay and biochemical properties. Clin Chim Acta 1980;103:79–90.
  27. Reiter C, Mwaluko G, Dunnette J, Van Loon JA, Weinshilboum RM: Thermolabile and thermostable human platelet phenolsulfotransferase: Substrate specificity and physical separation. Naunyn Schmiedeberg’s Arch Pharmacol 1983;324:140–147.
  28. Peterson GL: A simplification of the protein assay method which is more generally applicable. Anal Biochem 1977;83:346–356.
  29. Lepage P, Steiner M: Gender and serotonergic dysregulation: Implications for late luteal phase dysphoric disorder; in Cassano GB, Akiskal HS (eds): Serotonin-Related Psychiatric Syndromes: Clinical and Therapeutic Links. Int Congr Symp Series. London, Royal Society of Medicine Services, 1991, vol 165, pp 131–143.
  30. Wong CM, Hollander E: Headache response to m-chlorophenylpiperazine in obsessive-compulsive disorder and normal controls. Biol Psychiatry 1996;40:544–546.
  31. Steiner M, Lepage P, Dunn EJ: Serotonin and gender-specific psychiatric disorders. Int J Psychiatry Clin Pract 1997;1:3–13.
  32. Biegon A: Effects of steroid hormones on the serotonergic system. Ann NY Acad Sci USA 1990;600:427–434.
  33. Dawkins K, Potter WZ: Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: Focus on women. Psychopharmacol Bull 1991;27:417–426.
  34. Liebenluft E, Fiero PL, Rubinow DR: Effects of the menstrual cycle on dependent variables in mood disorders research. Arch Gen Psychiatry 1994;51:761–781.
  35. Nagayama H: Chronopharmacology of psychotropic drugs: Circadian rhythms in drug effects and its implications to rhythms in the brain. Pharmacol Ther 1993;59:31–54.

Article / Publication Details

First-Page Preview
Abstract of Biological PsychiatryMain Editor: J. Mendlewicz (Brussels)Original Paper

Published online: August 14, 1998
Issue release date: August 1998

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP